Ended

Kiplin

Shares

  • Healthcare
  • Good health & well being
Impact category Tech for good
Degree of maturity
Amount collected : € 359 473.02

Presentation

Today, in France, more than 10 million people suffer from chronic diseases (cancer, diabetes, cardiovascular diseases). For all these people, physical activity is a non-drug therapy. For example, in cancer treatment, physical activity reduces fatigue by 25% and reduces overall mortality by about 40% (CNIB Data 2017).

Kiplin offers a digital solution, accessible to everyone and everywhere. Each patient is invited to "play" by practising a physical activity adapted to his or her condition. The result: 70% of Kiplin users leave the sedentary threshold.

Based on data, this solution allows health care institutions to analyse the effects of the device on care in a concrete way.

The Kiplin solution is already used in institutions such as the IGR, the Gustave Roussy Institute (1st centre for the fight against cancer in Europe) or the APHP (Assistance Publique des Hôpitaux de Paris).

" style="" >

Kiplin offers a digital solution where each patient is invited to "play" by practising a physical activity.

1/2
Created by potrace 1.16, written by Peter Selinger 2001-2019

Reasons to invest

Risks related to the investment

Transaction conditions

Co-investor

Investment product conditions

Financial product
Minimum ticket
Financial benefit
Legal structure
Company valorization
% of capital reserved for LITA.co investors
Expected exit
Price per share
Governance
Amount collected
€ 359 473.02
Financial product
Share
Co-investor

Risques : investir dans des jeunes entreprises présente un risque important de perte partielle ou totale de capital ainsi qu’un risque d’illiquidité